Psoriatic arthritis (PsA) affects people in the prime of life, causing functional impairment and diminished quality of life. Etanercept, the first FDA-approved therapy, and other immunobiologics ...

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Psoriatic arthritis (PsA) is a type of arthritis that people with psoriasis may develop. Based on symptoms, doctors categorize PsA into five subtypes, which sometimes overlap. PsA affects about 20 ...

The study grouped 32,098 patients with psoriasis or psoriatic arthritis (PsA) into their respective categories based on biologic treatment, which included TNFi (n = 20,314), IL-17i (n = 5,073), IL ...

Do newer types of biologics increase the risk of MACE and VTE more than older TNFs in patients with psoriasis or psoriatic arthritis? Share on Facebook. Opens in a new tab or window Share on Bluesky.

such as psoriatic arthritis, inflammatory bowel disease and coronary artery disease. Approximately one-third of patients with psoriasis suffer from moderate to severe disease (Table 1) and report ...